Algert Global’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,935
| Closed | -$75K | – | 1305 |
|
|
2024
Q4 | $75K | Hold |
5,935
| – | – | ﹤0.01% | 1134 |
|
|
2024
Q3 | $95K | Hold |
5,935
| – | – | ﹤0.01% | 1119 |
|
|
2024
Q2 | $145K | Sell |
5,935
-801
| -12% | -$19.6K | ﹤0.01% | 1334 |
|
|
2024
Q1 | $484K | Buy |
6,736
+2,345
| +53% | +$168K | 0.02% | 768 |
|
|
2023
Q4 | $873K | Sell |
4,391
-3,358
| -43% | -$668K | 0.04% | 655 |
|
|
2023
Q3 | $1.03M | Sell |
7,749
-1,681
| -18% | -$223K | 0.05% | 564 |
|
|
2023
Q2 | $1.41M | Buy |
9,430
+186
| +2% | +$27.8K | 0.06% | 524 |
|
|
2023
Q1 | $1.36M | Buy |
9,244
+662
| +8% | +$97.2K | 0.06% | 506 |
|
|
2022
Q4 | $1.36M | Buy |
8,582
+6,872
| +402% | +$1.09M | 0.08% | 441 |
|
|
2022
Q3 | $329K | Buy |
1,710
+264
| +18% | +$50.8K | 0.02% | 929 |
|
|
2022
Q2 | $211K | Buy |
+1,446
| New | +$211K | 0.02% | 1011 |
|
|
2021
Q4 | – | Sell |
-1,395
| Closed | -$346K | – | 1086 |
|
|
2021
Q3 | $346K | Buy |
1,395
+295
| +27% | +$73.2K | 0.05% | 702 |
|
|
2021
Q2 | $280K | Sell |
1,100
-929
| -46% | -$236K | 0.09% | 302 |
|
|
2021
Q1 | $360K | Buy |
+2,029
| New | +$360K | 0.12% | 264 |
|